Brucellosis DNA vaccine
Brucellosis is a disease caused by facultative intracellular bacteria of the monospecific genus Brucella melitensis . The invention in one aspect is an immunogenic nucleic acid composition comprising DNA encoding Brucella melitensis Invasion Protein B, a polypeptide with at least 95% identity thereto, or an immunologically active fragment of either of these, and an adjuvant. In another aspect, the invention is a DNA vaccine composition comprising a plasmid vector having DNA encoding a polypeptide as recited above, in which said plasmid vector is adsorbed to a liposome. Other aspects of the invention include methods of inducing an enhanced immune response to Brucella infection in an animal, methods for the differential diagnosis in an animal of brucellosis and vaccination by an immunogenic nucleic acid composition having DNA encoding any of the above-recited polypeptides, and a kit for conducting said differential diagnosis methods.
1. An immunogenic nucleic acid composition comprising DNA encoding the polypeptide Brucella melitensis Invasion Protein B having an amino acid sequence as shown in SEQ ID NO: 12; and an adjuvant, wherein said adjuvant is a liposome.
2. A DNA vaccine composition comprising a plasmid vector having DNA encoding the polypeptide Brucella melitensis Invasion Protein B having an amino acid sequence as shown in SEQ ID NO: 12; in which said plasmid vector is adsorbed to a liposome.
3. The composition of claim 1 or 2 , which when administered to an animal subject induces an immune response that is characterized by enhancement of T cell priming and/or antibody generation compared with an immune response induced by a naked DNA vaccine encoding the corresponding polypeptide.
4. The composition of claim 1 or 2 , wherein said liposome is a cationic liposome.
5. The composition of claim 1 or 2 , wherein said DNA is passively adsorbed to said liposome.
6. The composition of claim 1 or 2 , wherein said DNA comprises the nucleotide sequence of SEQ ID NO: 11.
7. A lipid-formulated vaccine comprising DNA encoding the polypeptide Brucella melitensis Invasion Protein B having an amino acid sequence as shown in SEQ ID NO: 12.
8. The vaccine of claim 7 , wherein said DNA comprises the nucleotide sequence of SEQ ID NO: 11.
9. A method of inducing an enhanced immune response to Brucella infection in an animal, comprising administering to said animal an effective amount of the composition of claim 1 or 2 , or the vaccine of claim 7 , thereby inducing an enhanced immune response which is characterized in that it is greater in magnitude than an immune response induced by a naked DNA vaccine encoding the corresponding polypeptide.
10. The method of claim 9 , wherein said enhanced immune response is characterized by increased antibodies.
11. The method of claim 9 or 10 , wherein said enhanced immune response is characterized by enhanced T cell priming.
12. The method of claim 9 , in which said animal is a mammal.